ClinConnect ClinConnect Logo
Search / Trial NCT06874322

Voiceitt for People With Impairments in Speech

Launched by UNIVERSITY OF PITTSBURGH · Mar 7, 2025

Trial Information

Current as of April 26, 2025

Recruiting

Keywords

Speech Impairment Voice Recognition Tool Dictation Tool Voice Recognition App Dictation App Voiceitt App Speech Disabilities Dysarthria Moderate Dysarthria

ClinConnect Summary

This clinical trial is studying the Voiceitt app, which aims to help people with speech impairments communicate more effectively. The trial focuses on individuals who have difficulty speaking due to conditions like cerebral palsy, stroke, ALS (a type of motor neuron disease), or Parkinson's disease. By participating, individuals may see improvements in their ability to express themselves and engage in conversations.

To be eligible for this study, participants should be at least 13 years old and have moderately severe speech difficulties. They also need to be able to understand and follow instructions to use the app. However, individuals with severe cognitive issues that make it hard to understand the app, those with additional speech problems, or those who cannot engage with the app physically will not qualify. The trial is currently recruiting participants of all genders, and it's important to note that non-English speakers are not eligible. If you decide to participate, you can expect support in learning how to use the app and the opportunity to help improve communication tools for others in similar situations.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Age 13 or older
  • moderately severe speech dysarthria due to conditions such as CP, stroke, ALS or Parkinson's Disease, etc.
  • Ability to understand and follow instructions for using the Voiceitt app.
  • Exclusion Criteria:
  • Severe cognitive impairments that prevent the understanding of the Voiceitt app and required training.
  • Patients who have additional speech impairments other than dysarthria, such as significant aphasia or verbal apraxia.
  • Severe physical impairments that prevent interaction with the app.
  • Non-English speakers.

About University Of Pittsburgh

The University of Pittsburgh is a leading research institution known for its commitment to advancing medical science and improving patient care through innovative clinical trials. With a robust infrastructure for research and a multidisciplinary approach, the university fosters collaboration among experts in various fields, facilitating the development of novel therapies and interventions. Its clinical trial programs emphasize ethical standards, patient safety, and the integration of cutting-edge technology, making the University of Pittsburgh a pivotal contributor to the landscape of clinical research and a trusted partner in the pursuit of health advancements.

Locations

Pittsburgh, Pennsylvania, United States

Patients applied

0 patients applied

Trial Officials

Brad E Dicianno, MD

Principal Investigator

University of Pittsburgh

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported